Fungal nail infections: Diagnosis and management

Prescrire International

Volumn 18, Issue 99, 2009, Pages 26-30

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMOROLFINE; ANTIFUNGAL AGENT; BIFONAZOLE; CICLOPIROX; FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; ORAL CONTRACEPTIVE AGENT; PLACEBO; PYRROLE DERIVATIVE; TERBINAFINE; UREA;

ABDOMINAL PAIN; AGRANULOCYTOSIS; ANGIONEUROTIC EDEMA; ANTIFUNGAL ACTIVITY; APPLICATION SITE IRRITATION; BLOOD DISEASE; BURNING SENSATION; CANDIDA ALBICANS; CHOLESTATIC HEPATITIS; CLINICAL FEATURE; CLINICAL TRIAL; CREAM; DESQUAMATION; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DIZZINESS; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG EXCRETION; DRUG FATALITY; DRUG INDUCED HEADACHE; DRUG METABOLISM; ERYTHEMA; FATIGUE; FUNGUS CULTURE; FUNGUS IDENTIFICATION; GASTROINTESTINAL DISEASE; HAIR LOSS; HISTOPATHOLOGY; HUMAN; HYPERKERATOSIS; HYPESTHESIA; LABORATORY DIAGNOSIS; LIVER DISEASE; LIVER FAILURE; LIVER TOXICITY; MALAISE; NAUSEA; OCCLUSIVE DRESSING; OINTMENT; ONYCHOMYCOSIS; PARESTHESIA; PARONYCHIA; PRURITUS; PSORIASIS; REMISSION; REVIEW; RISK BENEFIT ANALYSIS; SKIN DISEASE; SKIN MACERATION; SKIN MANIFESTATION; SKIN SURGERY; STEVENS JOHNSON SYNDROME; TOENAIL ONYCHOMYCOSIS; TOXIC EPIDERMAL NECROLYSIS; TRICHOPHYTON RUBRUM;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ANTIFUNGAL AGENTS; AZOLES; CANDIDIASIS; DRUG THERAPY, COMBINATION; GRISEOFULVIN; HUMANS; LACQUER; NAPHTHALENES; OCCLUSIVE DRESSINGS; ONYCHOLYSIS; ONYCHOMYCOSIS; UREA;

EID: 59649111945     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Chabasse D "Peut-on chiffrer La fréquence des onychomycoses?" Ann Dermatol Vénéréol 2003; 130: 1222-1230.
2. Cribier B and Paul C "Long-term efficacy of antifungals in toenail onychomycosis: a critical review" Br J Dermatol 2001; 145: 446-452.
3. Crawford F and Ferrari J "Fungal toenail infections" search date June 2006. In: "Clinical Evidence" BMJ Publishing Group. London. www.clinicalevidence.com accessed 6 December 2007: 10 pages.
4. Duhard E et al. "Prise en charge des onychopathies présumées d'origine mycosique en dermatologie libérale" Ann Dermatol Vénéréol 2006; 133: 11-15.
5. Feuilhade De Chauvin M "Infections mycosiques et bactériennes de l'appareil unguéal" Rev Prat 2000; 50: 2223-2230.
6. Baudraz-Rosselet F et al. "Diagnostic et traitement des onychomycoses" Rev Méd Suisse 2005; 1 (16): 1069-1073.
7. "Fungal and candidal nail infections" Prodigy knowledge guidance May 2006. www.prodigy.nhs.uk accessed 18 October 2006: 24 pages.
8. Fouilloux B "Onychomycoses et qualité de vie" Ann Dermatol Vénéréol 2003; 130: 1275-1278.
9. Gupta AK and Summerbell RC "Combined distal and lateral subungual and white superficial onychomycosis in the toenails" J Am Acad Dermatol 1999; 41: 938-944.
10. Baran R et al. "A new classification of onychomycosis" Br J Dermatol 1998; 139: 567-571.
11. Feuilhade De Chauvin M and Lacroix C "Diagnostic différentiel des onychomycoses" Ann Dermatol Vénéréol 2003; 130: 1248-1253.
12. Goettmann-Bonvallot S "Variétés cliniques des onychomycoses" Ann Dermatol Vénéréol 2003; 130: 1237-1243.
13. Rodgers P and Bassler M "Treating onychomycosis" Am Fam Physician 2001; 63: 663-672.
14. Mahoney JM et al. "The diagnosis of onychomycosis" Dermatol Clin 2003; 21: 463-467.
15. Prescrire Editorial Staff" Amorolfine 5% nail lacquer" Prescrire Int 1993; 2 (5): 12-14.
16. Prescrire Rédaction "Psoriasis des adultes: des rémissions, mais pas de traitement curatif" Rev Prescrire 2005; 25 1266): 751-762.
17. Foulet F and Cremer G "Prélèvements et diagnostics mycologiques des onychomycoses?" Ann Dermatol Vénéréol 2003; 130: 1244-1247.
18. Scrivener Y "Onychomycoses. Analyse systématique des essais thérapeutiques" Ann Dermatol Vénéréol 2007; 134: 5S17-45.
19. "Modalités de diagnostic et prise en charge" Ann Dermatol Vénéréol 2007; 134 (suppl. 5): 7-16.
20. Crawford F and Hollis S "Topical treatments for fungal infections of the skin and nails of the foot" (Cochrane Review) (last updated in 2007). In: "The Cochrane library" John Wiley and Sons, Chichester 2007; issue 4: 127 pages.
21. Prescrire Editorial Staff "Ciclopirox, another nail lacquer" Prescrire Int 1993; 2 (5): 14.
22. Baran R and Richert B "Traitement des onychomycoses" Ann Dermatol Vénéréol 2003; 130: 1260-1271.
23. "Amorolfine". In: "Martindale The Complete Drug Reference" The Pharmaceutical Press, London. www.medicinescomplete.com accessed 5 December 2007: 2 pages.
24. "Ciclopirox". In: "Martindale The Complete Drug Reference" The Pharmaceutical Press, London. www.medicinescomplete.com accessed 5 December 2007: 3 pages.
25. Hay RJ "The future of onychomycosis therapy may involve a combination of approaches" Br J Dermatol 2001; 145: 3-8.
26. o pommade" Rev Prescrire 1996; 16 (164): 516-517 + 16 (165): 660.
27. Gupta AK et al. "Single-blind, randomised, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly" J Am Acad Dermatol 2001; 44: 479-484.
28. Grover C et al. "Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial" Br J Dermatol 2007; 157 (2): 364-368.
29. Robbins JM "Treatment of onychomycosis in the diabetic patient population" J Diabetes Complicat 2003; 17 (2): 98-104.
30. Prescrire Rédaction "Terbinafine" Rev Prescrire 1995; 15 (147): 9-11.
31. Jennings MB et al. "Treatment of toenail onychomycosis with oral terbinafine plus aggressive debridement: Iron-Clad, a large, randomized, openlabel, multicenter trial" J Am Podiatr Med Assoc 2006; 96 (6): 465-473.
32. "Terbinafine". In: "Martindale The Complete Drug Reference" The Pharmaceutical Press, London. www.medicinescomplete.com accessed 5 December 2007: 2 pages.
33. Potter LP et al. "The impact of aggressive debridement used as an adjunct therapy with terbinafine on perceptions of patients undergoing treatment for toenail onychomycosis" J Dermatol Treat 2007; 18 (1): 46-52.
34. Baran R et al. "A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoces affecting the matrix region" Br J Dermatol 2000; 142: 1177-1183.
35. Baran R et al. "A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement" Br J Dermatol 2007; 157(1): 149-157.
36. Prescrire Rédaction "Terbinafine et effets indésirables graves" Rev Prescrire 2005; 25 (258): 105.
37. Prescrire Editorial Staff "Terbinafine: agranulocytosis" Prescrire Int 2007; 16(89): 114.
38. Prescrire Rédaction "Terbinafine orale: des risques graves" Rev Prescrire 2007; 27 (287): 668.
39. Prescrire Rédaction "Fiche 1: le cytochrome P450 en bref" Rev Prescrire 2007; 27 (290 suppl. interactions médicamenteuses).
40. Baker JS et al. "Progress on new therapeutics for fungal nail infections" Annu Rep Med Chem 2005; 40: 323-334.
41. Prescrire Rédaction "Itraconazole: insuffisance cardiaque" Rev Prescrire 2007; 27 (287): 670.
42. Prescrire Rédaction "Les photodermatoses dues aux médicaments" Rev Prescrire 2000; 20 (205): 283-290.
43. Warshaw EM et al. "Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial" J Am Acad Dermatol 2005; 53 (4): 578-584.
44. Sigurgeirsson B et al. "Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: a randomized, double-blind comparison" J Dermatol Treat 2006; 17 (1): 38-44.